NLV-II
PersonMentions
0
Relationships
6
Events
4
Documents
0
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
Event Timeline
Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
6 total relationships
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
NLV-III
|
Successor fund |
5
|
1 | |
|
organization
IG
|
Investment portfolio |
5
|
1 | |
|
organization
iRhythm Technologies
|
Investment portfolio |
5
|
1 | |
|
organization
Treato
|
Investment portfolio |
5
|
1 | |
|
organization
STI
|
Portfolio company |
5
|
1 | |
|
organization
ICA
|
Financial |
2
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Intercept Pharmaceuticals IPO | Unspecified | View |
| 2013-04-01 | N/A | Chimerix IPO | NASDAQ | View |
| 2012-07-01 | N/A | Durata Therapeutics IPO | NASDAQ | View |
| 2011-11-01 | N/A | Synageva BioPharma reverse merger to become public | N/A | View |
No documents found for this entity.
Total Received
$4.25
2 transactions
Total Paid
$408,400,000.00
6 transactions
Net Flow
-$408,399,995.75
8 total transactions
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| N/A | Received | Array BioPharma | NLV-II | $2.25 | Investment exit multiple | View |
| N/A | Received | Epizyme | NLV-II | $2.00 | Investment exit multiple | View |
| N/A | Paid | NLV-II | Acadia Pharmaceut... | $0.00 | Investment exited at 2.5x. | View |
| N/A | Paid | NLV-II | Intercept Pharmac... | $0.00 | Anchored company's IPO, exited at 3.2x. | View |
| N/A | Paid | NLV-II | Audax Health | $0.00 | Investment exit noted at 3.4x return. | View |
| N/A | Paid | NLV-II | Array Pharmaceuti... | $0.00 | Structured follow-on investment, exited at 2.25x. | View |
| 2014-03-31 | Paid | NLV-II | LPs | $204,200,000.00 | Net Distributed $s to LPs | View |
| 2014-03-31 | Paid | NLV-II | Limited Partners ... | $204,200,000.00 | Net Distributed $s to LPs | View |
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity